News Minimal Differences Between Anti-VEGF Drugs on IOP Over Time by Medscape • 2017/06/01 • 0 Comments Patients on anti-VEGF therapy may have a small decrease in intraocular pressure (IOP) over time, but with minimal differences between aflibercept, ranibizumab, and bevacizumab, a new large study suggests. Reuters Health Information Full Story →